# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-051216
Filing Date
2025-04-04
Accepted
2025-04-04 16:59:51
Documents
32
Period of Report
2025-04-04

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | imab_investor_present_04.htm | 6-K | 25783
2 | EX-99.1 | imab-ex99_1.htm | EX-99.1 | 40552
3 | GRAPHIC | imab-ex99_1s1.jpg | GRAPHIC | 189174
4 | GRAPHIC | imab-ex99_1s2.jpg | GRAPHIC | 984532
5 | GRAPHIC | imab-ex99_1s3.jpg | GRAPHIC | 261659
6 | GRAPHIC | imab-ex99_1s4.jpg | GRAPHIC | 235768
7 | GRAPHIC | imab-ex99_1s5.jpg | GRAPHIC | 399812
8 | GRAPHIC | imab-ex99_1s6.jpg | GRAPHIC | 313724
9 | GRAPHIC | imab-ex99_1s7.jpg | GRAPHIC | 384747
10 | GRAPHIC | imab-ex99_1s8.jpg | GRAPHIC | 403023
11 | GRAPHIC | imab-ex99_1s9.jpg | GRAPHIC | 446557
12 | GRAPHIC | imab-ex99_1s10.jpg | GRAPHIC | 439253
13 | GRAPHIC | imab-ex99_1s11.jpg | GRAPHIC | 360670
14 | GRAPHIC | imab-ex99_1s12.jpg | GRAPHIC | 504743
15 | GRAPHIC | imab-ex99_1s13.jpg | GRAPHIC | 389083
16 | GRAPHIC | imab-ex99_1s14.jpg | GRAPHIC | 313389
17 | GRAPHIC | imab-ex99_1s15.jpg | GRAPHIC | 293427
18 | GRAPHIC | imab-ex99_1s16.jpg | GRAPHIC | 283006
19 | GRAPHIC | imab-ex99_1s17.jpg | GRAPHIC | 276537
20 | GRAPHIC | imab-ex99_1s18.jpg | GRAPHIC | 263903
21 | GRAPHIC | imab-ex99_1s19.jpg | GRAPHIC | 350660
22 | GRAPHIC | imab-ex99_1s20.jpg | GRAPHIC | 436439
23 | GRAPHIC | imab-ex99_1s21.jpg | GRAPHIC | 304510
24 | GRAPHIC | imab-ex99_1s22.jpg | GRAPHIC | 312973
25 | GRAPHIC | imab-ex99_1s23.jpg | GRAPHIC | 385688
26 | GRAPHIC | imab-ex99_1s24.jpg | GRAPHIC | 251229
27 | GRAPHIC | imab-ex99_1s25.jpg | GRAPHIC | 298671
28 | GRAPHIC | imab-ex99_1s26.jpg | GRAPHIC | 423642
29 | GRAPHIC | imab-ex99_1s27.jpg | GRAPHIC | 387234
30 | GRAPHIC | imab-ex99_1s28.jpg | GRAPHIC | 359022
31 | GRAPHIC | imab-ex99_1s29.jpg | GRAPHIC | 392223
32 | GRAPHIC | imab-ex99_1s30.jpg | GRAPHIC | 198500
| Complete submission text file | 0000950170-25-051216.txt |  | 14998009

Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 25815610
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)